Status In progress
Process STA
ID number 894

Provisional Schedule

Expected publication 25 April 2018

Project Team

Project lead Stephanie Yates

Email enquiries

Consultees

Companies sponsors Novartis (midostaurin)
Others Department of Health
  NHS England
  Welsh Government
Patient carer groups Bloodwise
  Leukaemia CARE
Professional groups Association of Cancer Physicians
  Cancer Research UK
  Royal College of Physicians
  Royal College of Radiologists

Commentators

Associated guideline groups None
Associated public health groups None
Comparator companies None
General commentators British National Formulary
  Department of Health, Social Services and Public Safety for Northern Ireland
  Healthcare Improvement Scotland
  Welsh Health Specialised Services Committee
Relevant research groups Institute of Cancer Research
  National Cancer Research Institute

Timeline

Key events during the development of the guidance:

Date Update
09 November 2017 Committee meeting: 1
25 May 2017 This appraisal has formally started and was planned to be discussed by the NICE appraisal committee on Wednesday 14 June 2017. However this has been rescheduled and the topic will now be appraised on Thursday 9 November 2017.
05 January 2017 Invitation to participate
22 July 2016 Referral

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance